Inhibitor κB-α haplotype GTC is associated with susceptibility to acute respiratory distress syndrome in Caucasians

Critical Care Medicine

Volumn 35, Issue 3, 2007, Pages 893-898

  Zhai, Rihong ^a   Zhou, Wei ^a   Gong, Michelle N ^c   Thompson, B Taylor ^b   Su, Li ^a   Yu, Chuling ^a   Kraft, Peter ^a   Christiani, David C ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Acute respiratory distress syndrome; Genetic susceptibility; Haplotype; NFKBIA; Polymorphism

Indexed keywords

I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PPP1R13L PROTEIN, HUMAN; RELA PROTEIN, HUMAN; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CAUCASIAN; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; COVARIANCE; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PROCEDURES; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; LUNG INJURY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; AGED; ANALYSIS OF VARIANCE; DRUG ANTAGONISM; GENETIC PREDISPOSITION; GENETICS; INTENSIVE CARE; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CRITICAL CARE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; I-KAPPA B PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; NF-KAPPA B; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RESPIRATORY DISTRESS SYNDROME, ADULT; RISK FACTORS; TRANSCRIPTION FACTOR RELA;

EID: 33947151685     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000256845.92640.38     Document Type: Article

References (42)

1. Piantadosi CA, Schwartz DA: The acute respiratory distress syndrome. Ann Intern Med 2004; 141:460-470
2. Hudson LD, Milberg JA, Anardi D, et al: Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1995; 151:293-301
3. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med 2000; 342:1334-1339
4. Gong MN, Zhou W, Xu LL, et al: Polymorphism in the surfactant protein-B gene, gender, and the risk of direct pulmonary injury and ARDS. Chest 2004; 125:203-211
5. Gong MN, Zhou W, Williams P, et al: -380GA and TNFB polymorphisms in acute respiratory distress syndrome. Eur Respir J 2005; 26:382-389
6. Marshall RP, Webb S, Bellingan GJ, et al: Angiotension converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Critic Care Med 2002; 166:646-650
7. Quasney MW, Waterer GW, Dahmer MK, et al: Association between surfactant protein B + 1580 polymorphism and the risk of respiratory failure in adults with communityacquired pneumonia. Crit Care Med 2004; 32:1115-1159
8. Mehta NM, Arnold JH. Genetic polymorphisms in acute respiratory distress syndrome: New approach to an old problem. Crit Care Med 2005; 33:2443-2445
9. Frerking I, Sengler C, Gunther A, et al: Evaluation of the -26G>A CC16 polymorphism in acute respiratory distress syndrome. Crit Care Med 2005; 33:2404-2406
10. Jerng JS, Yu CJ, Wang HC, et al: Polymorphism of the angiotensin- converting enzyme gene affects the outcome of acute respiratory distress syndrome. Crit Care Med 2006; 34:1001-1006
11. Gong MN, Zhou W, Williams PL, et al: Polymorphisms in the mannose binding lectin-2 gene and acute respiratory distress syndrome. Crit Care Med, In Press
12. Bhatia M, Moochhala S: Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 2004; 202:145-156
13. Puneet P, Moochhala S, Bhatia M: Chemokines in acute respiratory distress syndrome. AJP-Lung 2005; 288:3-15
14. Blackwell TS, Lancaster LH, Christman JW: Nuclear factor kappa B: A pivotal role in the systemic response syndrome and new target for therapy. Intensive Care Med 1998; 24:1131-1138
15. Huxford T, Huang DB, Malek S, et al: The crystal structure of the IkappaBalpha/NF-kappaB complex reveals mechanisms of NFkappaB inactivation. Cell 1998; 95:759-770
16. Christman JW, Sadikot RT, Blackwell TS: The role of nuclear factor-κ B in pulmonary diseases. Chest 2000; 117:1482-1487
17. Mozzato-Chamay N, Corbett EL, Bailey RL, et al: Polymorphisms in the Iκ B-α promoter region and risk of diseases involving inflammation and fibrosis. Genes Immun 2001; 2:153-155
18. Le Bail O, Schmidt-Ullrich R, Israel A: Promoter analysis of the gene encoding the Iκ B-α/ MAD3 inhibitor of NF-κ B: Positive regulation by members of the rel/ NF-κ B family. EMBO J 1993; 2:5034-5049
19. Ito CY, Kazantsev AG, Baldwin AS Jr: Three NF-kappa B sites in the I kappa B-alpha promoter are required for induction of gene expression by TNF alpha. Nucleic Acids Res 1994; 22:3787-3792
20. Abdallah A, Sato H, Grutters JC, et al: Inhibitor kappa B-alpha (Iκ B-α) promoter polymorphisms in UK and Dutch sarcoidosis. Genes and Immunity 2003; 4:450-454
21. Knaus WA, Wagner DP, Draper EA, et al: The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991; 100:1619-1636
22. Bernard GR, Artigas A, Brigham KL, et al: The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 25:203-211
23. Schaid DJ: General score tests for associations of genetic markers with disease using cases and their parents. Genet Epidemiol 1996; 3:423-449
24. Stram DO, Leigh Pearce C, Bretsky P, et al: Modeling and E-M estimation of haplotype-specific relative risks from genotype data for a case-control study of unrelated individuals. Hum Hered 2003; 55:179-190
25. Zaykin DV, Westfall PH, Young SS, et al: Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 2002; 3:79-91
26. Moss M, Guidot DM, Steinberg KP, et al: Diabetic patients have a decreased incidence of acute respiratory distress syndrome. Crit Care Med 2000; 28:2187-2192
27. Kraft P, Cox DG, Paynter RA, et al: Accounting for haplotype uncertainty in matched association studies: A comparison of simple and flexible techniques. Genet Epidemiol 2005; 28:261-272
28. Jacobs MD, Harrison SC: Structure of an IkappaBalpha/NF-kappa B complex. Cell 1998; 95:749-758
29. Parker KM, Ma MH, Manyak S, et al: Identification of polymorphisms of Iκ B-α gene associated with an increased risk of multiple myeloma. Cancer Genet Cytogenet 2002; 37:43-48
30. Haddad JJ, Land SC: Amiloride blockades lipopolysaccharide-induced proinflammatory cytokine biosynthesis in an I kappa B-alpha/NF-kappa B-dependent mechanism. Evidence for the amplification of an antiinflammatory pathway in the alveolar epithelium. Am J Respir Cell Mol Biol 2002; 26:114-126
31. Yoo CG, Lee S, Lee CT, et al: Anti-inflammatory effect of heat shock protein induction is related to stabilization of I kappa B alpha through prevention I kappa B kinase activation in respiratory epithelial cells. J Immunol 2000; 164:5416-5423
32. Haddad JJ, Land SC, Tarnow-Mordi WO, et al: Immunopharmacological potential of selective phosphodiesterase inhibition. II. Evidence for the involvement of an inhibitory-kappa B/nuclear factor-kappa B sensitive pathway in alveolar epithelial cells. J Pharmacol Exp Ther 2002; 300:567-576
33. Clark AG: The role of haplotypes in candidate gene studies. Genetic Epidemiol 2004; 27:321-333
34. The International HapMap Consortium. A haplotype map of the human genome. Nature 2005; 437:1299-1320
35. Leabman MK, Huang CC, De Young J, et al: Natural variation in human membrane transporter genes reveals evolutionary and functional constraints. Proc Natl Acad Sci U S A 2003; 100:5896-5901
36. Morris RW, Kaplan NL: On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles. Genet Epidemiol 2002; 23:221-233
37. Wizemann TM, Pardue M-L (Eds): Exploring the biological contributions to human health: Does sex matter? Washington DC, National Academy Press, 2001
38. Schroder J, Kahlke V, Staubach KH, et al: Gender differences in human sepsis. Arch Surg 1998; 133:1200-1205
39. Napolitano LM, Greco ME, Rodriguez A, et al: Gender differences in adverse outcomes after blunt trauma. J Trauma 2001; 50:274-280
40. Levy H, Raby BA, Lake S, et al: Association of defensin beta-1 gene polymorphisms with asthma. J Allergy Clin Immunol 2005; 115:252-258
41. Szczeklik W, Sanak M, Szczeklik A: Functional effects and gender association of COX-2 gene polymorphisms G-765C in bronchial asthma. J Allergy Clin Immunol 2004; 114:248-253
42. Miterski B, Böhringer S, Klein W, et al: Inhibitors in the NFκ B cascade comprise prime candidate genes predisposing to multiple sclerosis, especially in selected combinations. Genes Immnun 2002; 3:211-219